当前位置: X-MOL 学术JAMA › 论文详情
Treatment Decisions for a Future Self: Ethical Obligations to Guide Truly Informed Choices
JAMA ( IF 51.273 ) Pub Date : 2020-01-14 , DOI: 10.1001/jama.2019.19652
Claire J. Creutzfeldt; Robert G. Holloway

It is estimated that every 3 minutes in the United States, a person dies after sustaining a severe acute brain injury, such as an ischemic stroke, intracranial hemorrhage, traumatic brain injury, or cardiac arrest.1 Almost half of deaths after severe acute brain injury, 100 000 per year, occur during the acute hospitalization, and approximately 90% of patients die after a decision to limit the intensity of treatment rather than from the direct effects of the brain injury.1,2 The decision to continue or withdraw life-sustaining treatment usually involves asking a surrogate decision maker to balance the uncertain possibility that a patient will return to some minimally acceptable quality of life against the burden of a prolonged hospital and rehabilitation course, which are options that are difficult to predict and difficult to fathom. Prognostic uncertainty may manifest in 2 forms. First, how much will the patient recover? Will he or she walk again? Will he or she talk again? Will he or she be able to think and communicate meaningfully? Second, will the patient come to terms with the new possible disability? Will he or she consider life to have quality? With the aging of the population, advances in acute treatment options, and changing intensive care unit practices, such issues are likely to become more frequent.1,2
更新日期:2020-01-14

 

全部期刊列表>>
2020新春特辑
限时免费阅读临床医学内容
ACS材料视界
科学报告最新纳米科学与技术研究
清华大学化学系段昊泓
自然科研论文编辑服务
加州大学洛杉矶分校
上海纽约大学William Glover
南开大学化学院周其林
课题组网站
X-MOL
北京大学分子工程苏南研究院
华东师范大学分子机器及功能材料
中山大学化学工程与技术学院
试剂库存
天合科研
down
wechat
bug